JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholtysik, G.
Right arrow Articles by Brown, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholtysik, G.
Right arrow Articles by Brown, A. M.

5-Hydroxytryptamine antagonist ICS 205-930 blocks cardiac potassium, sodium and calcium currents

G Scholtysik, Y Imoto, A Yatani and AM Brown

Department of Physiology and Molecular Biophysics, Baylor College of Medicine, Texas Medical Center, Houston.

Effects of the 5-hydroxytryptamine receptor antagonist ICS 205-930 [(3 alpha-tropanyl)-1H-indole-3-carboxylic acid ester] on cardiac membrane currents were investigated in single isolated ventricular cells using the whole-cell patch clamp method. Ca++ and K+ currents were studied in guinea pig ventricular cells and Na+ currents were studied in ventricular cells from cultured neonatal rat; these cells are more suitable for Na+ current measurements than are ventricular cells from guinea pig. Under current clamp conditions, ICS 205-930 at 3 x 10(-5) M prolonged the action potential plateau and increased its amplitude of guinea pig cell. The effect was reversible. Increasing the concentration to 3 x 10(-4) M shortened the plateau, reduced its amplitude and depolarized the resting membrane potential. The effects between 10(-7) and 10(-3) M were examined under voltage-clamp conditions. ICS 205-930 produced a concentration-dependent suppression of inwardly rectifying K+ currents with an IC50 of 1.95 x 10(-5) M at a test potential of -40 mV. The effects were time-and voltage-dependent and the IC50 increased to 1.16 x 10(-4) M at -100 mV. The time- dependent outward current and the time-dependent outward tail currents upon repolarization to between -10 and -30 mV also were blocked by the drug in a concentration-dependent manner with IC50 of 3.7 x 10(-5) M. Ca++ currents and Na+ currents also were inhibited in the presence of higher concentration of ICS 205-930 (greater than 10(-4) M), although potency was stronger on Na+ currents. The results show that ICS 205-930 exerts mixed class III and class I antiarrhythmic properties in ventricular myocytes.

Volume 245, Issue 3, pp. 773-778, 06/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Mine, T. Yoshikawa, S. Oku, R. Nagai, N. Yoshida, and K. Hosoki
Comparison of Effect of Mosapride Citrate and Existing 5-HT4 Receptor Agonists on Gastrointestinal Motility In Vivo and In Vitro
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1000 - 1008.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.